Capture assays optimization

Once the optimal conditions have been established, the capture assays can be used in several ways. 

The capture assay is optimized to detect the Ag I trapped on the plates using Ab. The competition is achieved in which Ag2 is mixed with the Ab in the liquid phase. If this reacts, the amount of Ab available for reaction with the trapped Agl is reduced. 

Assessing the resources available for method development should also be done before beginning a project. The resources available include not only HPLCs, detectors, and columns, but also tools for sample preparation, data capture and analysis software, trained analysts, and especially samples representative of the ultimate analyte matrix. Also, it should be considered whether a fast, secondary method of analysis can be used to optimize sample preparation steps. Often, a simple colorimetric or fluorimetric assay, without separation, can be used for this purpose. A preliminary estimate of the required assay throughput will help to guide selection of methods. 

There are several important advantages RPMAs have over antibody arrays and other proteomic techniques such as immunohis-tochemistry or tissue arrays. Antibody arrays usually require a second specific antibody, made in a different species, for each captured protein to be visualized in a manner analogous to enzyme-linked immunosorbent assays (ELISA). Therefore, it becomes difficult to simultaneously optimize the antibody-antigen hybridization conditions for so many antibodies at once present on antibody arrays while minimizing nonspecific cross-reactivity and ensuring that proteins over a wide range of concentrations can be quantitated in a linear fashion (14). Antibody arrays also consume or require much higher inputs of protein than reverse phase arrays. With antibody arrays. 

Make a dilution of the capture antibody in coating buffer from 0.5 to 10 pg/mL and use to coat ELISA wells. The binding capacity of ELISA wells may be reduced if the concentration of antibody is not optimal. Overdilution, and paradoxically underdilution may lead to poor well binding. In some competition ELISA assays up to 100 pg/mL may be required. 

Antibody capture of viruses can be used as a preparatory step in nucleic acid amplification techniques. Immunocapture of virus particles can be used to streamline and/or optimize the concentration, purification and specificity requirements of polymerase chain reaction assays. 

A further issue is the steric hindrance the interaction properties in a homogeneous assay are not directly transferable to the binding conditions at a surface/ interface. The binding site of an immobilized capture molecule is accessible only from one side. It must be exposed on the surface in an optimal manner. Likewise, the capturing partner, e.g., peptide or protein, should be oriented with its binding-active domain toward the sample solution. 

The HCV helicase assay is linearly dependent on enzyme concentration up to 60 fmol with 250 fmol of dsRNA substrate (Fig. 3). The optimal time of incubation for the assay was determined by a time course experiment. Capture oligomer-coated FlashPlatePLUS wells containing 250 fmol of dsRNA and 10 fmol of helicase per reaction were incubated at 37°C, with stop solution being added at the time points shown in Fig. 4. The formation of ssRNA product as measured by cpm or graphed as percent of displaced ssRNA product was linearly dependent on time up to 60 min. Based on these data, 250 fmol of dsRNA... 

An isothermal nncleic acid sequence-based amplification (NASBA) assay was optimized to amplify viral RNA of all four dengue virus serotypes by a set of universal primers and to type the amplified products by serotype-specific capture probes. The NASBA assay involved the use of silica to extract viral nucleic acid, which was amplified without thermocycling (Wu et al. 2001a). The main advantage of this assay over a PCR technique is that it is entirely isothermal and is conducted at 41°C. Thus, it would be suitable for epidemiological studies in the field (Wu et al. 2001a). 

As with all assays, each reagent must be adjusted to optimize test performance. A lateral flow test that is visually read is complicated by the fact that the interpretation of test results is subjective, dependent on ambient conditions and the experience of the tester. For this reason, it is preferable to use an instrumented reader to interrogate lateral flow test results. Recently, new inexpensive readers have become available. One such device (Avagotech, Menlo Park, CA) utilizes an inexpensive CCD camera, such as those found in mobile phones along with simple electronics to capture images of the lateral flow strip and its capture lines. Other more sophisticated reader devices are also available. The costs for any reader are dependant upon the capabilities of the reader hardware and software. Newer systems are now under development for fluorescence and chemilumenescent analysis. This new generation of readers is expected to increase lateral flow test analytical capabilities considerably. 

Reagents and reference materials Likely will change but should have some documentation on early characterization Continue to screen for optimal reagents Lot no. and history (notebook reference) Evaluate different reagents and identify critical reagents Determine if sufficient quantities are available and their stability for later bioanalytical needs Include C of A for reference materials in assay validation documents Keep records of source and lot no. Use optimized capture/ detection reagents Use characterized reference standard from final manufacturing process with Cof A Record all lot nos. and sources... 

---